Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
Giulia MorsicaSabrina BagaglioVincenzo SpagnuoloAntonella CastagnaClelia Di SerioAndrea GalliLiviana Della TorreAndrea AndolinaAlexander PramovCaterina Uberti-FoppaPublished in: PloS one (2017)
Our data suggest that testing for anti-HBc alone may not be a reliable means of assessing protection from HBV infection in HIV-positive patients. OBI-positive patients may benefit from a single vaccine dose. Anti-HCV serostatus may affect PRs.
Keyphrases
- hiv positive
- end stage renal disease
- men who have sex with men
- immune response
- antiretroviral therapy
- chronic kidney disease
- south africa
- ejection fraction
- newly diagnosed
- prognostic factors
- hepatitis b virus
- human immunodeficiency virus
- patient reported outcomes
- dendritic cells
- electronic health record
- liver failure